I

IX Biopharma Ltd
SGX:42C

Watchlist Manager
IX Biopharma Ltd
SGX:42C
Watchlist
Price: 0.017 SGD Market Closed
Market Cap: 15.1m SGD

Intrinsic Value

42C's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one 42C stock under the Base Case scenario is 0.029 SGD. Compared to the current market price of 0.017 SGD, IX Biopharma Ltd is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

42C Intrinsic Value
0.029 SGD
Undervaluation 42%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation History
IX Biopharma Ltd

Valuation History Unavailable

Historical valuation for 42C cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare 42C to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 42C?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about IX Biopharma Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
IX Biopharma Ltd

Current Assets 5.6m
Cash & Short-Term Investments 2.1m
Receivables 2.1m
Other Current Assets 1.4m
Non-Current Assets 7.5m
PP&E 7.1m
Intangibles 273k
Other Non-Current Assets 92k
Efficiency

Free Cash Flow Analysis
IX Biopharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
IX Biopharma Ltd

Revenue
7m SGD
Cost of Revenue
-5.7m SGD
Gross Profit
1.3m SGD
Operating Expenses
-8.4m SGD
Operating Income
-7.1m SGD
Other Expenses
-2.6m SGD
Net Income
-9.7m SGD
Fundamental Scores

42C Profitability Score
Profitability Due Diligence

IX Biopharma Ltd's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

IX Biopharma Ltd's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

42C Solvency Score
Solvency Due Diligence

IX Biopharma Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
32/100
Solvency
Score

IX Biopharma Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

42C Price Targets Summary
IX Biopharma Ltd

There are no price targets for 42C.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

IX Biopharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for 42C is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one 42C stock?

The intrinsic value of one 42C stock under the Base Case scenario is 0.029 SGD.

Is 42C stock undervalued or overvalued?

Compared to the current market price of 0.017 SGD, IX Biopharma Ltd is Undervalued by 42%.

Back to Top